#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma refractory Chronic graft versus host disease in liver Leiomyosarcoma Ventricular tachycardia Extra-osseous Ewing's sarcoma metastatic Myxoid liposarcoma Macular telangiectasia Spinal cord injury cervical PIK3CA related overgrowth spectrum Haemophagocytic lymphohistiocytosis Haemolytic uraemic syndrome Pyoderma gangrenosum Marginal zone lymphoma Kaposi's sarcoma KBG syndrome More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Treatment Synovial sarcoma – Diagnostics Lymphangiosarcoma Leukoencephalopathy – Trials in Disease Shprintzen-Goldberg syndrome Mucopolysaccharidosis – Treatment Waldenstrom’s macroglobulinaemia recurrent Activated PI3 kinase delta syndrome – Treatment Kearns-Sayre syndrome – Life with Disease Glycogen storage disease type V – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desloratadine Dronabinol AP31969 SULFATE Enalapril Domperidone Warfarin Sodium Ulipristal Acetate Buserelin Acetate Phleum Pratense (225) Cinchocaine Hydrochloride Dexchlorpheniramine Lactic Acid GSKVX000000034792 Rosuvastatin Zinc Lucerastat Clic-1901 Cart Pasireotide Hmb-001 Omp12 Ebastine More therapies…

    Learn about Your Condition

    Relapsing multiple sclerosis Bronchiectasis Osteosarcoma Vulvovaginal pain Gastrointestinal carcinoma Hidradenitis Radiation skin injury Hypertrophic cardiomyopathy Hepatitis B Malignant glioma Metastatic neoplasm Progressive supranuclear palsy Hypotension Circulatory collapse Hysterectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Myelofibrosis

  • Study on the Safety and Effectiveness of Fedratinib and Azacitidine for Patients with Accelerated Phase Myelofibrosis

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Fedratinib
    • Azacitidine
    Germany

  • Study of Gandotinib for Patients with Myeloproliferative Neoplasms, Myelofibrosis, Essential Thrombocythemia, or Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myeloproliferative neoplasm
    • Essential thrombocythaemia
    • Polycythaemia vera
    Investigated Drugs:
    • Gandotinib
    Austria Germany Spain

  • Study on Treosulfan, Fludarabine Phosphate, and Thiotepa for Patients with Myelofibrosis Undergoing Haplo-identical Transplantation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Treosulfan
    • Thiotepa
    • Fludarabine Phosphate
    France

  • Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

    Not recruiting

    2 1 1 1 1
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    • Ruxolitinib
    Italy Poland

  • Study on KER-050 and Ruxolitinib for Patients with Myelofibrosis and Anemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaemia
    • Myelofibrosis
    Investigated Drugs:
    • Elritercept
    • Ruxolitinib
    France Italy Spain

  • Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease in intestine
    • Acute graft versus host disease in liver
    • Acute graft versus host disease in skin
    Investigated Drugs:
    • Panobinostat
    • Siremadlin
    • Ruxolitinib
    Germany Italy Poland Sweden
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!